Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma

Overview of attention for article published in Cancer Immunology, Immunotherapy, September 2004

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent: 5 patents

Citations

dimensions_citation: 46 Dimensions

Readers on

mendeley: 27 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

Methods of using IL-21 for adoptive immunotherapy and identification of tumor antigens

Grant US-11306289-B2

United States of America

Method for treating Stage IV melanoma

Grant US-10111941-B2

United States of America

Methods of using IL-21 for adoptive immunotherapy and identification of tumor antigens

Grant US-9951310-B2

United States of America

Method for treating stage IV melanoma

Grant US-9463226-B2

United States of America

METHOD FOR TREATING STAGE IV MELANOMA

Application WO-2007109825-A1

World Intellectual Property Organisation (WIPO)